Silva Francisco — SEC Form 4 filings

SEC reporting owner CIK 1527241. 5 Form 4 filings on record with FilingPulse; latest filed 2025-10-20.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-15 to 2025-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BioRestorative Therapies, Inc. (BRTX)VP of Research and Development, Director53 legs · 8,308 sh · $10,2295

Form 4 filings — Silva Francisco

FiledFormIssuerReported transactionsSource
2025-10-204BioRestorative Therapies, Inc. (BRTX)Grant/award (A): 11,719 @ $1.60 · Grant/award (A): 11,719 (derivative) @ $0EDGAR
2025-02-194BioRestorative Therapies, Inc. (BRTX)Grant/award (A): 768,979 (derivative) @ $0EDGAR
2024-04-104BioRestorative Therapies, Inc. (BRTX)Purchase (P): 476 @ $1.13 · Purchase (P): 1,232 @ $1.17 · Purchase (P): 6,600 @ $1.25EDGAR
2024-03-204BioRestorative Therapies, Inc. (BRTX)Tax withholding (F): 17,193 @ $1.39EDGAR
2024-02-154BioRestorative Therapies, Inc. (BRTX)Grant/award (A): 394,737 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1527241 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →